Leibniz Research Network Immune-mediated Diseases
Online-Symposium: 27th and 28th of September 2021
We are delighted to invite you to participate in the Online-Symposium of the Leibniz Research Network Immune-Mediated Diseases, to be held on the 27th and 28th of September 2021.
The focus of the symposium is to present concepts and technologies available within our network, thus fostering collaboration, brainstorming and providing a platform for interdisciplinary exchange. Participating groups will have the opportunity to introduce their research and expertise in techniques and technologies through brief introductory presentations. Small break-out sessions will provide an opportunity for networking, scientific discussion and idea exchange.
As this year the symposium is organized by the postdocs of the participating Leibniz Institutes, and we want them to be the stars of the meeting! Therefore, we strongly encourage introductory presentations to be made by postdocs.
We look forward to welcoming you virtually to our symposium! For any queries or further information, please contact
Leibniz Research Network Immune-Mediated Diseases Symposium Organization Team
|13:00||Welcome by the organizing team|
|13:10||Welcome note by Prof. Andreas Radbruch|
|13:20||Network Immune-mediated Diseases – What is our goal|
|13:40||Introductory presentations by the participating groups – Session I|
|14:20||Introductory presentations by the participating groups – Session II|
|14:50||Best practices for a successful interdisciplinary collaboration – Prof. Chiara Romagnani|
|15:10||Introductory presentations by the participating groups – Session III|
|16:00||Introductory presentations by the participating groups – Session IV|
|17:00||End of Day 1 – quick recap by organizers|
|9:00||Welcome by the organizing team|
|9:15||1st Breakout-Room networking session|
|10:00||Brief presentation of results by moderators|
|10:30||2nd Breakout-Room networking session|
|11:15||Brief presentation of results by moderators|
|11:30||Leibniz Research Network Immune-mediated Diseases General Assembly|